Discordant expression of LFA-1, VLA-4a, VKA-β1, CD45RO and CD28 on T-cell subsets : evidence for multiple subsets of memory T cellsKERN, F; DÖCKE, W. D; REINKE, P et al.International archives of allergy and immunology. 1994, Vol 104, Num 1, pp 17-26, issn 1018-2438Article

Quantitative determination of CD4/CD8 molecules by a cell marker ELISAFRANKE, L; NUGEL, E; DÖCKE, W.-D et al.Clinical chemistry (Baltimore, Md.). 1994, Vol 40, Num 1, pp 38-42, issn 0009-9147Article

Pentoxifylline promotes replication of human cytomegalovirus in vivo and in vitroSTAAK, K; PRÖSCH, S; STEIN, J et al.Blood. 1997, Vol 89, Num 10, pp 3682-3690, issn 0006-4971Article

Late acute rejection in renal allograft recipients is mediated by inflammatory rather than by cytotoxic T-cell-dependent mechanismsODE-HAKIM, S; DÖCKE, W.-D; MUTZE, S et al.Transplantation proceedings. 1997, Vol 29, Num 1-2, pp 93-95, issn 0041-1345Conference Paper

Late acute rejection in long-term renal allograft recipients : diagnostic and predictive value of circulating activated T cellsREINKE, P; FIETZE, E; DÖCKE, W.-D et al.Transplantation. 1994, Vol 58, Num 1, pp 35-41, issn 0041-1337Article

Immunological monitoring of the inflammatory process : Which variables? When to assess?VOLK, H.-D; REINKE, P; DÖCKE, W.-D et al.European journal of surgery. Supplement. 1999, Num 584, pp 70-72, issn 1102-416XArticle

Enhanced expression of T-cell activation and natural killer cell antigens indicates systemic anti-tumor response in early primary cutaneous T-cell lymphomaASADULLAH, K; FRIEDRICH, M; DÖCKE, W.-D et al.Journal of investigative dermatology. 1997, Vol 108, Num 5, pp 743-747, issn 0022-202XConference Paper

Inflammatorische Mediatoren bei Patienten mit biventrikulären Assist-Device-Systemen = Inflammatory mediators in patients with Biventricular Assist Device SystemsHASPER, D; HUMMEL, M; DÖCKE, W.-D et al.Zeitschrift für Kardiologie (Print). 1996, Vol 85, Num 11, pp 820-827, issn 0300-5860Article

Subclinical activation of latent cytomegalovirus (CMV) infection and anti-CMV immune response in patients with atopic dermatitisDÖCKE, W.-D; KIESSLING, C; ASADULLAH, K et al.British journal of dermatology (1951). 2003, Vol 148, Num 5, pp 954-963, issn 0007-0963, 10 p.Article

Interleukin 10 treatment of psoriasis: Clinical results of a phase 2 trialASADULLAH, K; DÖCKE, W.-D; EBELING, M et al.Archives of dermatology (1960). 1999, Vol 135, Num 2, pp 187-192, issn 0003-987XArticle

Influence of monomethylfumarate on monocytic cytokine formation : explanation for adverse and therapeutic effects in psoriasis?ASADULLAH, K; SCHMID, H; FRIEDRICH, M et al.Archives of dermatological research (Print). 1997, Vol 289, Num 11, pp 623-630, issn 0340-3696Article

IL-15 and IL-16 overexpression in cutaneous T-cell lymphomas : stage-dependent increase in mycosis fungoides progressionASADULLAH, K; HAEUSSLER-QUADE, A; GELLRICH, S et al.Experimental dermatology. 2000, Vol 9, Num 4, pp 248-251, issn 0906-6705Article

Interleukin-10 in cutaneous disorders : implications for its pathophysiological importance and therapeutic useASADULLAH, K; SABAT, R; WIESE, A et al.Archives of dermatological research (Print). 1999, Vol 291, Num 12, pp 628-636, issn 0340-3696Article

Immunodepression following neurosurgical proceduresKHUSRU ASADULLAH; WOICIECHOWSKY, C; DÖCKE, W.-D et al.Critical care medicine. 1995, Vol 23, Num 12, pp 1976-1983, issn 0090-3493Article

Induction of long-term survival of rat skin allografts by a novel, highly efficient anti-CD4 monoclonal antibodyLEHMANN, M; STERNKOPF, F; METZ, F et al.Transplantation. 1992, Vol 54, Num 6, pp 959-962, issn 0041-1337Article

Impaired antigen presentation by human monocytes during endotoxin toleranceWOLK, K; DÖCKE, W.-D; VON BAEHR, V et al.Blood. 2000, Vol 96, Num 1, pp 218-223, issn 0006-4971Article

Mechanisms of endotoxin tolerance in patients with alcoholic liver cirrhosis: role of interleukin 10, interleukin 1 receptor antagonist, and soluble tumour necrosis factor receptors as well as effector cell desensitisationVON BAEHR, V; DÖCKE, W.-D; PLAUTH, M et al.Gut. 2000, Vol 47, Num 2, pp 281-287, issn 0017-5749Article

Interferon Gamma-1b in the treatment of compensatory anti-inflammatory response syndrome : A new approach : Proof of principleKOX, W. J; BONE, R. C; VOLK, H.-D et al.Archives of internal medicine (1960). 1997, Vol 157, Num 4, pp 389-393, issn 0003-9926Article

Verrucosis of hands and feet in a patient with combined immune deficiencyASADULLAH, K; RENZ, H; DÖCKE, W.-D et al.Journal of the American Academy of Dermatology. 1997, Vol 36, Num 5, pp 850-852, issn 0190-9622, 2Article

Monocyte deactivation : rationale for a new therapeutic strategy in sepsisVOLK, H.-D; REINKE, P; KRAUSCH, D et al.Intensive care medicine. Supplement. 1996, Vol 22, Num 4, pp S474-S481, issn 0935-1701Article

Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteersHARTUNG, T; DÖCKE, W.-D; GANTNER, F et al.Blood. 1995, Vol 85, Num 9, pp 2482-2489, issn 0006-4971Article

Cytokine expression in primary cutaneous germinal center cell lymphomasASADULLAH, K; GELLRICH, S; HAEUSSLER-QUADE, A et al.Experimental dermatology. 2000, Vol 9, Num 1, pp 71-76, issn 0906-6705Article

Interleukin-10 in der Dermatologie = Interleukin-10 in dermatologyASADULLAH, K; DÖCKE, W.-D; SABAT, R et al.Hautarzt. 1999, Vol 50, Num 1, pp 12-19, issn 0017-8470Article

A high prevalence of cytomegalovirus antigenaemia in patients with moderate to severe chronic plaque psoriasis : an association with systemic tumour necrosis factor α overexpressionASADULLAH, K; PRÖSCH, S; AUDRING, H et al.British journal of dermatology (1951). 1999, Vol 141, Num 1, pp 94-102, issn 0007-0963Article

Mechanisms of brain-mediated systemic anti-inflammatory syndrome causing immunodepressionWOICIECHOWSKY, C; SCHÖNING, B; LANKSCH, W. R et al.Journal of molecular medicine (Berlin. Print). 1999, Vol 77, Num 11, pp 769-780, issn 0946-2716Article